2 shares to buy for the FTSE 100 recovery

As the FTSE 100 (INDEXFTSE:UKX) climbs above 7,000 again, Paul Summers picks out two stocks he’d buy for the ongoing recovery.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Tracking the FTSE 100 is an option for cautious investors wanting to buy shares in 2021. However, I think I can make better money buying those stocks that have the potential to gain the most from the ongoing market recovery.

Today, I’m looking at two examples from the top tier. As luck would have it, both reported on trading this morning.  

Smith & Nephew

FTSE 100 medical technology company Smith & Nephew (LSE: SN) is first up. By contrast to other members of the index, its share price is still far off its pre-Covid-19 highs. Based on the reaction to today’s Q1 statement, I think time could be running out to acquire this company at a good price.

[fool_stock_chart ticker=LSE:SN)

At $1.13bn, revenue over the three months to 3 April came in 11.5% higher on a reported basis compared to the same period last year. While some of this is the result of currency tailwinds and input from acquisitions, CEO Roland Diggelmann reflected that surgery volumes were “moving towards more normal levels in many markets.

Importantly, all three of S&N’s franchises (Orthopaedics, Sports Medicine & ENT and Advanced Wound Management) have bounced back to growth. Tellingly, a strong rebound in revenue in the Chinese market gives some indication of how business in developed markets might perform once Covid-19 is defeated. 

Interestingly, S&N chose not to alter its 2021 guidance on revenue growth and profit margin today. I think this is prudent. After all, operations and treatments could still be impacted by a significant third wave in 2021, highlighting that no FTSE 100 stock is devoid of risk

With talk of “improving visibility” however, I’m tempted to believe we could begin to see the S&N share price really recover from here as postponed elective surgeries get the green light. A price-to-earnings (P/E) ratio of 24 looks punchy, but not after the potential growth is factored in. I’m sorely tempted to pile in. 

Flutter Entertainment

To label gambling firm Flutter Entertainment (LSE: FLTR) a recovery play may sound strange. After all, its share price has already climbed 65% over the last year. 

[fool_stock_chart ticker=LSE:FLTR)

However, like S&N, I’m inclined to think we could see more gains ahead, especially once the sporting calendar gets back to normal and retail betting outlets and stadiums are allowed to reopen.

Again, like S&N, today’s Q1 trading update made for very pleasant reading. Total revenue rose 32% to £1.49bn over the first three months of 2021. Unsurprisingly, the vast majority of this was online where player growth of 36% was also recorded. 

Unlike its FTSE 100 peer, however, this news hasn’t been quite so well received. To me, this suggests that a lot of positivity was already priced in. After all, the betting operator’s shares were already changing hands for 50 times earnings.

A predicted rise in UK coronavirus infection rates may have brought forth some profit-taking. Investors  may also speculate that people will be less inclined to place bets if they’re concerned about where levels of employment might be going once the full economic cost of the pandemic is realised.

That said, I think I’d be tempted to buy some Flutter today and add in bouts on any weakness. The growth opportunities, particularly in the US, are hard to ignore. Moreover, a price/earnings-to-growth (PEG) ratio of 1.4 isn’t excessive. Anything below 1.0 tends to be indicative of good value.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers has no position in any of the shares mentioned. The Motley Fool UK owns shares of Flutter Entertainment. The Motley Fool UK has recommended Smith & Nephew. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

How I’d invest my first £20k ISA to target £4,900 a year from dividend shares

Looking for dividend shares in a new Stocks and Shares ISA, and want diversification too? Here's how I'd go about…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »